Evidence map›Paper›PMID 27867864›Full record

ReviewGland surgery2016

Agnieszka Czarniecka, Małgorzata Oczko-Wojciechowska, Marcin Barczyński

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Gland surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Breaking barriers: noninvasive AI model for BRAFInternational journal of computer assisted radiology and surgery · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. BRAFMedical journal of the Islamic Republic of Iran · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Agnieszka CzarnieckaDepartment of Oncological and Reconstructive Surgery Center of Oncology, M. Sklodowska-Curie Memorial Institute, Gliwice Branch, Poland.
Małgorzata Oczko-WojciechowskaDepartment of Nuclear Medicine and Endocrine Oncology Center of Oncology, M. Sklodowska-Curie Memorial Institute, Gliwice Branch, Poland.
Marcin BarczyńskiDepartment of Endocrine Surgery, Third Chair of General Surgery, Jagiellonian University, Medical College, Kraków, Poland.
Jagiellonian University · PLThe Maria Sklodowska-Curie National Research Institute of Oncology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary thyroid cancer (PTC) offers excellent prognosis, however relapse risk or persistent disease is related to ~30%. Currently, attention is paid to the possibility of patient group selection of different risk of unfavorable outcome to match a particular therapeutic approach. Therefore, interest in new prognostic and predictive markers known preoperatively is observed.

Indexed as

BRAF V600E mutationcancer recurrencePapillary thyroid cancer (PTC)risk-stratification

Identifiers

PMID27867864
PMCPMC5106385
OpenAlexW2543419234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.